Results 181 to 190 of about 98,172 (269)

Targeted degradation of oncogenic BCR-ABL by silencing the gene of NEDD8 E3 ligase RAPSYN. [PDF]

J Nanobiotechnology
Sun Y, Wang Y, Liu C, Huang Y, Long Q, Ju C, Zhang C, Chen Y.   +7 more
europepmc   +1 more source

Splenic rupture as the presenting symptom of blastic crisis in a patient with Philadelphia-negative, bcr-abl-positive ET [PDF]

, 2000
Chor Sang Chim, Yok‐Lam Kwong, Tony W.H. Shek, Edmond S.K., G.C. Ooi   +4 more
openalex   +1 more source

Rationally designed BCR-ABL kinase inhibitors for improved leukemia treatment via covalent and pro-/dual-drug targeting strategies. [PDF]

J Adv Res
Sun J, Lou L, Zhu C, Chen P, Tang G, Gu M, Xia S, Dong X, Zhang ZM, Gao L, Yao SQ, Xiao Q.   +11 more
europepmc   +1 more source

Role of alpha1 Acid Glycoprotein in the In Vivo Resistance of Human BCR-ABL+ Leukemic Cells to the Abl Inhibitor STI571

, 2000
Carlo Gambacorti‐Passerini
openalex   +1 more source

Bcr‐Abl activates AURKA and AURKB in chronic myeloid leukemia cells via AKT signaling

International Journal of Cancer, 2014
Jing Yang, T. Ikezoe, C. Nishioka, K. Udaka, A. Yokoyama   +4 more
semanticscholar   +1 more source

The Survival Function of the Bcr-Abl Oncogene Is Mediated by Bad-Dependent and -Independent Pathways: Roles for Phosphatidylinositol 3-Kinase and Raf

, 2000
Mehran S. Neshat, Arthur Raitano, Hong‐Gang Wang, John C. Reed, Charles L. Sawyers   +4 more
openalex   +1 more source

Correction: Weber et al. Stat5 Exerts Distinct, Vital Functions in the Cytoplasm and Nucleus of Bcr-Abl⁺ K562 and Jak2(V617F)⁺ HEL Leukemia Cells. <i>Cancers</i> 2015, <i>7</i>, 503-537. [PDF]

Cancers (Basel)
Weber A, Borghouts C, Brendel C, Moriggl R, Delis N, Brill B, Vafaizadeh V, Groner B.   +7 more
europepmc   +1 more source

Manifold-assisted Reverse Transcription-PCR with Real-Time Detection for Measurement of the BCR-ABL Fusion Transcript in Chronic Myeloid Leukemia Patients

, 2000
Gisela Barbany, Anette Hagberg, Ulla Olsson‐Strömberg, Bengt Simonsson, Ann‐Christine Syvänen, Ulf Landegren   +5 more
openalex   +1 more source

Bcr-abl kinase inhibition as the basis of therapy for cml

, 2000
Brian J. Druker, Moshe Talpaz, Debra Resta, Bin Peng, Eliasbeth Buchdunger, J. Ford, Charles L. Sawyers   +6 more
openalex   +1 more source